Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Amrubicin receives FDA orphan drug designation for small cell lung cancer

March 26, 2008

New phase Ib trial evaluates NPI-2358 for NSCLC

March 26, 2008

Cell Therapeutics completes enrollment for pixantrone phase III EXTEND trial in NHL

March 26, 2008

Seattle Genetics begins phase I trial of SGN-33 plus Revlimid in MDS patients

March 26, 2008

Mifamurtide now available through compassionate access study

March 25, 2008

Genzyme withdraws EU application to extend Evoltra and plans to resubmit

March 25, 2008

New compounds for the treatment of cancer disclosed in recent patent literature

March 25, 2008

BioNumerik and ASKA present results from phase III Tavocept trial

March 20, 2008

Cytopia selects JAK2 clinical candidate for myeloproliferative disorders

March 20, 2008

PhytoMedical to initiate third phase of drug development program for novel anticancer compounds

March 20, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...